Loading...
PI3K isoform-selective inhibitors: next-generation targeted cancer therapies
The pivotal roles of phosphatidylinositol 3-kinases (PI3Ks) in human cancers have inspired active development of small molecules to inhibit these lipid kinases. However, the first-generation pan-PI3K and dual-PI3K/mTOR inhibitors have encountered problems in clinical trials, with limited efficacies...
Na minha lista:
| Udgivet i: | Acta Pharmacol Sin |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648175/ https://ncbi.nlm.nih.gov/pubmed/26364801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2015.71 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|